Diversified Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Diversified Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-58,749	Closed	-$2.13M	–	278
2016 Q4	$2.13M	Buy	58,749 +42	+0.1%	+$1.68K	0.18%	64
2016 Q3	$2.7M	Buy	58,707 +1,100	+2%	+$57.4K	0.32%	50
2016 Q2	$2.89M	Buy	57,607 +9,770	+20%	+$520K	0.33%	55
2016 Q1	$2.56M	Hold	47,837	–	–	0.28%	83
2015 Q4	$3.14M	Buy	47,837 +1,000	+2%	+$61.8K	0.34%	62
2015 Q3	$2.64M	Sell	46,837 -30,327	-39%	-$1.97M	0.28%	81
2015 Q2	$4.56M	Sell	77,164 -893	-1%	-$55.1K	0.43%	36
2015 Q1	$4.86M	Buy	78,057 +1,047	+1%	+$60.9K	0.42%	35
2014 Q4	$4.43M	Buy	+77,010	New	+$4.29M	0.4%	40
2014 Q2	$3.38M	Buy	+64,500	New	+$3.3M	0.28%	60

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Diversified Trust's TEVA Position: Q1 2017 in Review

Diversified Trust sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 58,749 shares — an estimated $2.13M sold.

Diversified Trust first reported a position in TEVA in Q2 2014 and held it in 10 quarters. The position peaked at $4.86M in Q1 2015. 688 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

Diversified Trust reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Diversified Trust sold 58,749 Teva Pharmaceuticals shares in Q1 2017, an estimated $2.13M.
Diversified Trust first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 10 quarters.
Diversified Trust's Teva Pharmaceuticals position peaked at $4.86M in Q1 2015.
688 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Diversified Trust's 13F filing for Q1 2017, filed 21 Apr 2017.